CAMBRIDGE, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new ...
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
Beam Therapeutics (NASDAQ:BEAM) shared promising results from the early stage trial of its genetically modified cell therapy, BEAM-101, for the treatment of severe sickle cell disease. The data ...
Kyivstar signed a deal to give customers in Ukraine access to Starlink's space-based cell service. Customers will be able to send text messages if the terrestrial network is down, Kyivstar said.
The low-angle neutron scattering instrument transferred from the Paul Sherrer Institute in Switzerland is in place at the Argentine Neutron Beam Laboratory. (Image: CNEA) The transfer of the ...
This study delves into the efficacy of external strengthening methods in improving the shear behavior of defected reinforced concrete (RC) beams that lack shear stirrups, utilizing both experimental ...
MIT researchers have developed a miniature, chip-based “tractor beam,” like the one that captures the Millennium Falcon in the film “Star Wars,” that could someday help biologists and clinicians study ...
MADRID, June 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported data highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results